Skip to main content
. 2020 Jul 28;11:1505. doi: 10.3389/fimmu.2020.01505

Figure 2.

Figure 2

ANA increased in patients with active cGVHD. (A) The proportion of patients with different severities of cGVHD according to different ANA titers. (B) Stratified analysis for factors associated with the presence of ANA. The black bars in the forest plot indicate odds ratios with 95% confidence intervals for each variable. cGVHD, chronic graft-vs.-host disease; ANA, anti-nuclear autoantibodies; 95% CI, 95% confidence interval; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; HLA, human leukocyte antigen; BM, bone marrow; PBSC, peripheral blood stem cell; ATG, antithymocyte globulin.